Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.

Journal of cancer research and clinical oncology - 1 Jul 2023

Chaluts Danielle, Dullea Jonathan T, Ali Muhammad, Vasan Vikram, Devarajan Alex, Rutland John W, Gill Corey M, Ellis Ethan, Kinoshita Yayoi, McBride Russell B, Bederson Joshua, Donovan Michael, Sebra Robert, Umphlett Melissa, Shrivastava Raj K

Abstract excerpt

PURPOSE: The oncologic outcomes for atypical meningiomas can be poor. Generally, patients that have had a prior recurrence have a substantially elevated risk of a future recurrence. Additionally, certain tumor genomic profiles have been shown as markers of poor prognosis. We sought to characterize the genomic differences between primary and recurrent tumors as well as assess if those differences had implications...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA-Binding Proteins
Share to Meningeal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Meningioma

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Prognosis

Share to Progression-Free Survival

Share to Transcription Factors

Source

Identifiers

PMID: 36348021
DOI: 10.1007/s00432-022-04442-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas.PMID 36348021Read ↗

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free SurvivalSemantic proximity Read ↗

Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.Semantic proximity Read ↗

Genomic markers of recurrence risk in atypical meningioma following gross total resectionSemantic proximity Read ↗

Mutational Analysis of Recurrent Meningioma Progressing From Atypical to Rhabdoid Subtype.Semantic proximity Read ↗

NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.Semantic proximity Read ↗

Risk Factors and Genomic Characteristics of Recurrent Meningiomas Identified Through Routine Clinical TestingSemantic proximity Read ↗

Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA ProfilingSemantic proximity Read ↗

Progression-Free Survival and Molecular Features of Recurrent Intracranial Meningiomas: A Single-Center Retrospective StudySemantic proximity Read ↗

NF2 mutation associated with accelerated time to recurrence for older patients with atypical meningiomas.Semantic proximity Read ↗

Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomasSemantic proximity Read ↗

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumorsSemantic proximity Read ↗

Mutation Status and Epithelial Differentiation Stratify Recurrence Risk in Chordoid Meningioma—A Multicenter Study with High Prognostic RelevanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.